FMUCX
Price
$15.48
Change
-$0.01 (-0.06%)
Updated
Sep 16 closing price
Net Assets
1.39B
HBLSX
Price
$15.21
Change
-$0.01 (-0.07%)
Updated
Sep 16 closing price
Net Assets
11.96B
Interact to see
Advertisement

FMUCX vs HBLSX

Header iconFMUCX vs HBLSX Comparison
Open Charts FMUCX vs HBLSXBanner chart's image
Federated Hermes Muni and Stock Adv C
Price$15.48
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets1.39B
Hartford Balanced Income R4
Price$15.21
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets11.96B
FMUCX vs HBLSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FMUCX vs. HBLSX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMUCX is a Buy and HBLSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLSX has more cash in the bank: 12B vs. FMUCX (1.39B). HBLSX pays higher dividends than FMUCX: HBLSX (3.17) vs FMUCX (1.30). FMUCX was incepted earlier than HBLSX: FMUCX (22 years) vs HBLSX (15 years). FMUCX (1.83) is less costly to investors than HBLSX (0.96). HBLSX is a more actively managed with annual turnover of: 61.00 vs. FMUCX (23.00). HBLSX has a lower initial minimum investment than FMUCX: HBLSX (0) vs FMUCX (1500). FMUCX annual gain was more profitable for investors over the last year : 6.07 vs. HBLSX (2.41). FMUCX return over 5 years is better than : 25.75 vs. HBLSX (15.94).
FMUCXHBLSXFMUCX / HBLSX
Total Expense Ratio1.740.96181%
Annual Report Gross Expense Ratio1.830.96191%
Fund Existence22 years15 years-
Gain YTD5.8498.52069%
Front LoadN/AN/A-
Min. Initial Investment15000-
Min. Initial Investment IRA250N/A-
Net Assets1.39B12B12%
Annual Yield % from dividends1.303.1741%
Returns for 1 year6.072.41251%
Returns for 3 years25.3318.96134%
Returns for 5 years25.7515.94162%
Returns for 10 years46.8647.4599%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBIGF0.180.01
+7.68%
Paradigm Biopharmaceuticals Ltd.
ERVFF0.03N/A
N/A
Boron One Holdings Inc.
PHGUF1.50N/A
N/A
Pharming Group NV
NRKBY13.80N/A
N/A
NKT A/S
SWDBY29.75-0.06
-0.20%
Swedbank AB